Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wanzel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Neuroendocrinology|October 27, 2020
Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated DeathSami Matrood, Nicola de Prisco, Thaddeus T Wissniowski, et al.
Molecular Cancer|October 3, 2022
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferaseNastasja Merle, Sabrina Elmshäuser, Florian Strassheimer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5Fotini Vogiatzi, Dominique T Brandt, Jean Schneikert, et al.
Signal Transduction and Targeted Therapy|March 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsNiklas Gremke, Isabelle Besong, Alina Stroh, et al.
Nature Genetics|January 8, 2025
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutationsJulianne S Funk, Maria Klimovich, Daniel Drangenstein, et al.
Cell Death and Differentiation|April 23, 2022
IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivityDennis Das Gupta, Christoph Paul, Nadine Samel, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Neuroendocrinology|October 27, 2020
Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated DeathSami Matrood, Nicola de Prisco, Thaddeus T Wissniowski, et al.
Molecular Cancer|October 3, 2022
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferaseNastasja Merle, Sabrina Elmshäuser, Florian Strassheimer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5Fotini Vogiatzi, Dominique T Brandt, Jean Schneikert, et al.
Signal Transduction and Targeted Therapy|March 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsNiklas Gremke, Isabelle Besong, Alina Stroh, et al.
Nature Genetics|January 8, 2025
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutationsJulianne S Funk, Maria Klimovich, Daniel Drangenstein, et al.
Cell Death and Differentiation|April 23, 2022
IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivityDennis Das Gupta, Christoph Paul, Nadine Samel, et al.
Pageof 3